4Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med, 2008, 178 : 332-338.
5Fenton C, Keating GM. Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease. Drugs, 2004, 64: 1975-1996.
6Wood-Baker R, Waiters J, Waiters EH. Systemic corticosteroids in chronic obstructive pulmonary disease : an overview of Cochrane systematic reviews. Respir Med, 2007, 101: 371-377.
7Culpitt SV, Rogers DF, Shah P, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2003, 167: 24-31,.
8Barnes PJ. New molecular targets for the treatment of neutrophilic diseases. J Allergy Clin Immunol, 2007, 119: 1055-1062.
9Pujols L, Mullol J, Roca-Ferrer J, et al. Expression of glucocotticoid receptor alpha- and beta-isoforms in human cells and tissues. Am J Physiol Cell Physiol, 2002, 283: C1324-C1331.
10Marwick JA, Caramori G, Stevenson CS, et al. Inhibition of PI3Kdeha restores glucocorticoid function in smoking-induced airway inflammation in mice. Am J Respir Crit Care Med, 2009, 179 : 542-548.
